MET and neoplasm: Other targets of miR-199a include the tumor-promoting p21 (RAC1) activated kinase 4 (PAK4), the mammalian target of rapamycin (mTOR) and c-Met, which have been described as tumor suppressors in the context of HCC [102,103,104,105].